CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The main purpose of this study is to evaluate the safety, tolerability, and recommended phase 2 target dose of tarlatamab in combination with AMG 404.
Phase 1
Salt Lake City, Utah, United States and 16 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Salt Lake City, Utah, United States and 209 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Salt Lake City, Utah, United States and 200 other locations
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 30 other locations
of lurbinectedin with irinotecan (Group B) versus Investigator's Choice (topotecan or irinotecan) as control arm (Group C), in Small-cell Lung...
Phase 3
Salt Lake City, Utah, United States and 213 other locations
The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, c...
Phase 3
Salt Lake City, Utah, United States and 123 other locations
osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non-small cell lung...
Phase 3
Salt Lake City, Utah, United States and 117 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Salt Lake City, Utah, United States and 262 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer...
Phase 3
Ogden, Utah, United States and 275 other locations
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Ogden, Utah, United States of America and 122 other locations
Clinical trials
Research sites
Resources
Legal